Table of Contents Table of Contents
Previous Page  294 320 Next Page
Information
Show Menu
Previous Page 294 320 Next Page
Page Background

1.

Introduction

Androgen deprivation therapy (ADT) is extensively used in

the management of prostate cancer (PCa) but is associated

with an array of adverse effects

[1] .

One adverse effect

which has a considerable impact on quality of life is fatigue

and a substantial proportion of men with PCa suffer from

fatigue, with 40% or more of those on long-term ADT

reporting chronic fatigue or clinically-relevant fatigue

which interferes with daily functioning

[2]

.

Exercise interventions have shown positive effects on

reducing or mitigating fatigue

[3] .

As a result, recent expert

reviews in urology/oncology have incorporated aerobic and

resistance exercise interventions as evidence-based strategies

to mitigate toxicities from ADT including fatigue

[1,4]

. We

[5,6]

and others

[7,8]

have reported in relatively short-term

trials (

<

6 mo) of progressive resistance (strength) training

and/or aerobic exercise consisting of walking/jogging or

cycling at moderate to high intensity can reduce or prevent

the worsening of fatigue, as can the same exercise modes

when combined with dietary advice/behavioural components

in a lifestyle intervention

[9,10]

. However, these studies have

examined only the effects of short-term interventions with

longer-term outcomes rarely reported. Importantly, advance-

ments to exercise protocols/prescription are required to

understand the potential of different exercise modalities on

fatigue. Accordingly, we report for the first time the efficacy of

a 1-y long randomised controlled trial (RCT) of varying

exercise interventions in PCa patients undergoing ADT with

changes in fatigue and vitality assessed over 6 mo and 12 mo.

2.

Patients and methods

2.1.

Patients

Two-hundred and ninety-three patients with PCa were screened for

participation from 2009 to September 2012 at Perth, Western Australia

and Brisbane, Queensland and their progress through the study is

detailed in

Fig. 1

. Inclusion criteria included histologically documented

PCa, minimum exposure to ADT of 2 mo, without prostate-specific

antigen (PSA) evidence of disease activity, and anticipated to receive ADT

for the subsequent 12 mo. Exclusion criteria included bone metastatic

disease, musculoskeletal, cardiovascular, or neurological conditions that

could inhibit them from exercising, inability to walk 400 m or undertake

exercise, and structured resistance and aerobic training in the previous

3 mo. All participants obtained medical clearance from their physician.

The study was approved by the University Human Research Ethics

Committee and all participants provided written informed consent.

2.2.

Study design and random assignment

This was a three-armed RCT. Primary endpoints were bone mineral

density and cardiovascular capacity

[11]

, which will be reported

elsewhere, with secondary endpoints including physical function and

self-reported patient outcomes. Potential participants were primarily

identified by their treating urologist/oncologist and referred to the study

coordinator to confirm eligibility, describe the study, and obtain informed

consent. Study patients underwent a familiarisation session that included

correct exercise technique followed by baseline testing comprising

physical tests, questionnaires, and a venous blood sample. Following

baseline assessment, participants were stratified according to time on

ADT (

<

6 mo or

6 mo) and randomly allocated to: impact

loading + resistance training (ILRT), aerobic + resistance training (ART),

or to usual care/delayed exercise (DEL) by computer random assignment.

2.3.

Exercise training program

ILRT was undertaken twice weekly in University-affiliated exercise

clinics for 12 mo. Sessions were supervised with up to 10 participants.

The impact-loading component consisted of a series of bounding,

skipping, drop jumping, hopping, and leaping activities that produced

ground reaction forces of 3.4–5.2 times body weight, and was

progressive in nature. Specific details on progression are described

elsewhere

[11]

. Resistance training consisted of six principal exercises

that targeted the major upper and lower body muscle groups: chest

press, seated row, shoulder press, leg press, leg extension, and leg curl,

with supplementary exercises. Patients performed two to four sets of

each exercise at an intensity of 6–12 RM (maximal weight that can be

lifted 6–12 times). In addition, the ILRT group undertook home training

twice weekly that consisted of two to four rotations of skipping/hopping/

leaping/drop jumping

[11]

. ART underwent supervised exercise in the

clinic twice weekly for the initial 6 mo. The aerobic-based component

consisted of 20–30 min of exercise at 60–75% of estimated maximal

heart rate using various modes which included walking/jogging and

cycling or rowing on stationary ergometers. Resistance exercise during

the initial 6 mo was the same as that undertaken in the ILRT regimen. In

addition, participants were encouraged to undertake home-based

aerobic activity such as walking or cycling with the goal to accumulate

150 min/wk of aerobic activity. For the 2nd 6 mo, patients were provided

with a home-based maintenance program similar to our previous report

[12]

. DEL were provided with a printed booklet with information about

exercise for the initial 6mo, followed by 6mo of twice weekly supervised

exercise on a cycle ergometer at an intensity of 70% maximal heart rate

and flexibility exercises in the clinic. During the 12-mo study period,

ILRT, ART, and DEL were asked to maintain customary physical activity

and dietary patterns.

2.4.

Fatigue and vitality

Study endpoints of fatigue and vitality were assessed at baseline, 6 mo,

and 12 mo. Fatigue was assessed using the European Organisation for

Research and Treatment of Cancer Quality of Life Questionnaire Core 30

(EORTC QLQ-C30;

Table 1 )

. Fatigue is a three-item symptom subscale

with higher scores representing greater fatigue

[13] .

Vitality (energy

level and fatigue) was assessed with the Short Form-36 Health Survey

(SF-36;

Table 1

)

[14]

. The Vitality scale of the SF-36 is a four-item

subdomain measure with scores ranging from 0 to 100, with higher

values indicting more vitality

[15]

.

Patient summary:

We compared the effects of different exercise modes on fatigue in men

on androgen deprivation therapy. All exercise programs reduced fatigue and enhanced

vitality. We conclude that undertaking some form of exercise will help reduce fatigue,

especially in those who are the most fatigued.

#

2017 European Association of Urology. Published by Elsevier B.V. This is an open access

article under the CC BY-NC-ND license

( http://creativecommons.org/licenses/by-nc-nd/4.0/

).

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 2 9 3 – 2 9 9

294